Metabolic brain networks associated with cognitive function in Parkinson's disease

NeuroImage

Volumn 34, Issue 2, 2007, Pages 714-723

  Huang, Chaorui ^a,b   Mattis, Paul ^a,c   Tang, Chengke ^a,b   Perrine, Kenneth ^c   Carbon, Maren ^a,b   Eidelberg, David ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

Cognitive function; FDG PET; Network analysis; PD

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN REGION; CEREBELLUM VERMIS; CLINICAL ARTICLE; COGNITION; CORRELATION COEFFICIENT; DATA ANALYSIS; DENTATE NUCLEUS; DEPTH PERCEPTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MEMORY; MENTAL PERFORMANCE; PARKINSON DISEASE; POSITRON; PRIORITY JOURNAL; RELIABILITY; STATISTICAL ANALYSIS; VALIDATION PROCESS;

BRAIN; COGNITION; COGNITION DISORDERS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; NERVE NET; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; PRINCIPAL COMPONENT ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 34548369547     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2006.09.003     Document Type: Article

References (76)

1. Aasland D., Zaccai J., and Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov. Disord. 20 (2005) 1255-1263
2. Army Individual Test Battery. Manual of Directions and Scoring (1944), War Department, Adjutant General's Office, Washington, DC
3. Alexander G.E., and Moeller J.R. Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: a principal component approach to modeling brain function in disease. Hum. Brain Mapp. 2 (1994) 1-16
4. Asanuma K., Ma Y., Huang C., et al. The metabolic pathology of dopa-responsive dystonia. Ann. Neurol. 57 (2005) 596-600
5. Asanuma K., Tang C., Ma Y., et al. Network modulation in the treatment of Parkinson's disease. Brain 129 Pt. 10 (2006) 2667-2678
6. Beck A. Beck Depression Inventory: Manual (1987), Psychological Corporation, San Antonio, TX
7. Binder J.R., Frost J.A., Hammeke T.A., Bellgowan P.S., Rao S.M., and Cox R.W. Conceptual processing during the conscious resting state. A functional MRI study. J. Cogn. Neurosci. 11 (1999) 80-95
8. Bland J.M., and Altman D.G. Measurement error. BMJ 313 (1996) 744
9. Bohnen N.I., Kaufer D.I., Ivanco L.S., et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch. Neurol. 60 (2003) 1745-1748
10. Bosboom J.L., Stoffers D., and Wolters E. Cognitive dysfunction and dementia in Parkinson's disease. J. Neural Transm. 111 (2004) 1303-1315
11. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24 (2003) 197-211
12. Braak H., Rub U., Jansen Steur E.N., Del Tredici K., and de Vos R.A. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64 (2005) 1404-1410
13. Brück A., Portin R., Lindell A., et al. Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci. Lett. 311 (2001) 81-84
14. Brück A., Kurki T., Kaasinen V., Vahlberg T., and Rinne J.O. Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment. J. Neurol. Neurosurg. Psychiatry 75 (2004) 1467-1469
15. Brück A., Aalto S., Nurmi E., Bergman J., and Rinne J.O. Cortical 6-[18F]fluoro-l-dopa uptake and frontal cognitive functions in early Parkinson's disease. Neurobiol. Aging 26 (2005) 891-898
16. Carbon M., and Marié R.M. Functional imaging of cognition in Parkinson's disease. Curr. Opin. Neurol. 16 (2003) 475-480
17. Carbon M., Edwards C., and Eidelberg D. Functional brain imaging in Parkinson's disease. Adv. Neurol. 91 (2003) 175-181
18. Carbon M., Ghilardi M.F., Feigin A., et al. Learning networks in health and Parkinson's disease: reproducibility and treatment effects. Hum. Brain Mapp. 19 (2003) 197-211
19. Carbon M., Ma Y., Barnes A., et al. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism. NeuroImage 21 (2004) 1497-1507
20. Cheesman A.L., Barker R.A., Lewis S.J., Robbins T.W., Owen A.M., and Brooks D.J. Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 76 (2005) 1204-1210
21. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neurosci. Biobehav. Rev. 30 (2006) 1-23
22. Cools R., Stefanova E., Barker R.A., Robbins T.W., and Owen A.M. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 125 (2002) 584-594
23. Dagher A., Owen A.M., Boecker H., and Brooks D.J. Mapping the network for planning: a correlational PET activation study with the Tower of London task. Brain 122 Pt. 10 (1999) 1973-1987
24. Delis D.C., Kramer J.H., Kaplan E., and Ober B.A. California Verbal Learning Test: Adult Version (1987), The Psychological Corporation, San Antonio
25. Dum R.P., Li C., and Strick P.L. Motor and nonmotor domains in the monkey dentate. Ann. N. Y. Acad. Sci. 978 (2002) 289-301
26. Eckert T., and Eidelberg D. Neuroimaging and therapeutics in movement disorders. NeuroRx 2 (2005) 361-371
27. Eckert, T., Van Laere, K., Lewis, D.E., Edwards, C., Santens, P., Eidelberg, D., in press. Quantification of PD-related network expression with ECD SPECT. Eur. J. Nucl. Med. Mol. Imaging.
28. Efron B., and Tibshirani R. An Introduction To The Bootstrap (1994), CRC Press, New York
29. Eidelberg D. Functional brain networks in movement disorders. Curr. Opin. Neurol. 11 (1998) 319-326
30. Eidelberg D., Moeller J.R., Dhawan V., et al. The metabolic topography of parkinsonism. J. Cereb. Blood Flow Metab. 14 (1994) 783-801
31. Eidelberg D., Moeller J.R., Ishikawa T., et al. Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET. J. Nucl. Med. 36 (1995) 378-383
32. Eidelberg D., Moeller J.R., Kazumata K., et al. Metabolic correlates of pallidal neuronal activity in Parkinson's disease. Brain 120 (1997) 1315-1324
33. Emre M. What causes mental dysfunction in Parkinson's disease?. Mov. Disord. 18 Suppl. 6 (2003) S63-S71
34. Emre M., Aarsland D., Albanese A., et al. Rivastigmine for dementia associated with Parkinson's disease. N. Engl. J. Med. 351 (2004) 2509-2518
35. Feigin A., Antonini A., Fukuda M., et al. Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Mov. Disord. 17 (2002) 1265-1270
36. Folstein M.F., Folstein S.E., and McHugh P.R. " Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975) 189-198
37. Goldon C. Stroop Color and Word Test (1978), Stoelting Company, Chicago
38. Green J., McDonald W.M., Vitek J.L., et al. Cognitive impairments in advanced PD without dementia. Neurology 59 (2002) 1320-1324
39. Gusnard D.A., and Raichle M.E. Searching for a baseline: functional imaging and the resting human brain. Nat. Rev. Neurosci. 2 (2001) 685-694
40. Habeck C., Krakauer J.W., Ghez C., et al. A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis. Neural. Comp. 17 (2005) 1602-1645
41. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., and Curtiss G. Wisconsin Card Sorting Test Manual-Revised and Expanded (1993), Psychological Assessment Resources, Inc., Odessa
42. Hilker R., Thomas A.V., Klein J.C., et al. Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways. Neurology 65 (2005) 1716-1722
43. Hooper H.E. Hooper Visual Orientation Test (VOT) (1983), Western Psychological Services, Los Angeles
44. Hoshi E., Tremblay L., Feger J., Carras P.L., and Strick P.L. The cerebellum communicates with the basal ganglia. Nat. Neurosci. 8 (2005) 1491-1493
45. Huang C., Carbon M., Mattis P., and Eidelberg D. Metabolic patterns associated with cognitive function in Parkinson's disease. Mov. Disord. 21 (2006) S104
46. Huang, C., Eidelberg, D., Habeck, C., et al., in press. Imaging markers of mild cognitive impairment: multivariate analysis of cross-sectional and longitudinal CBF SPECT. Neurobiol. Aging. (Electronic publication ahead of print, 2006 July 3)
47. Jellinger K.A., Seppi K., Wenning G.K., and Poewe W. Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. J. Neural Transm. 109 (2002) 329-339
48. Jueptner M., and Weiller C. Review: does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI. NeuroImage 2 (1995) 148-156
49. Kaplan, E., Goodglass, H., and Weintraub, S., 1978. The Boston Naming Test. Kaplan, E., Goodglass, H., Boston.
50. Kovari E., Gold G., Herrmann F.R., et al. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease. Acta Neuropathol. (Berl.) 106 (2003) 83-88
51. Levin B.E., Llabre M.M., Reisman S., et al. Visuospatial impairment in Parkinson's disease. Neurology 41 (1991) 365-369
52. Lozza C., Baron J.C., Eidelberg D., Mentis M.J., Carbon M., and Marie R.M. Executive processes in Parkinson's disease: FDG-PET and network analysis. Hum. Brain Mapp. 22 (2004) 236-245
53. Ma, Y., Tang, C., Spetsieres, P., Dhawan, V., Eidelberg, D., in press. Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J. Cereb. Blood Flow Metab. (Electronic publication ahead of print, 2006 June 28)
54. MacDonald V., and Halliday G.M. Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease. Mov. Disord. 17 (2002) 1166-1173
55. Marié R.M., Barre L., Dupuy B., Viader F., Defer G., and Baron J.C. Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease. Neurosci. Lett. 260 (1999) 77-80
56. Massman P.J., Delis D.C., Butters N., Levin B.E., and Salmon D.P. Are all subcortical dementias alike? Verbal learning and memory in Parkinson's and Huntington's disease patients. J. Clin. Exp. Neuropsychol. 12 (1990) 729-744
57. Mattay V.S., Tessitore A., Callicott J.H., et al. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann. Neurol. 51 (2002) 156-164
58. McKiernan K.A., Kaufman J.N., Kucera-Thompson J., and Binder J.R. A parametric manipulation of factors affecting task-induced deactivation in functional neuroimaging. J. Cogn. Neurosci. 15 (2003) 394-408
59. Mentis M.J., McIntosh A.R., Perrine K., et al. Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease. Am. J. Psychiatry 159 (2002) 746-754
60. Mentis M.J., Dhawan V., Nakamura T., et al. Enhancement of brain activation during trial-and-error sequence learning in early PD. Neurology 60 (2003) 612-619
61. Moeller J.R., Ishikawa T., Dhawan V., et al. The metabolic topography of normal aging. J. Cereb. Blood Flow Metab. 16 (1996) 385-398
62. Moeller J.R., Nakamura T., Mentis M.J., et al. Reproducibility of regional metabolic covariance patterns: comparison of four populations. J. Nucl. Med. 40 (1999) 1264-1269
63. Muslimovic D., Post B., Speelman J.D., and Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65 (2005) 1239-1245
64. Nakamura T., Ghilardi M.F., Mentis M., et al. Functional networks in motor sequence learning: abnormal topographies in Parkinson's disease. Hum. Brain Mapp. 12 (2001) 42-60
65. Owen A.M. Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry. The Neuroscientist 10 (2004) 525-535
66. Pillon B., Czernecki V., and Dubois B. Dopamine and cognitive function. Curr. Opin. Neurol. 16 Suppl. 2 (2003) S17-S22
67. Rinne J.O., Portin R., Ruottinen H., et al. Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Arch. Neurol. 57 (2000) 470-475
68. Rombouts S.A., Barkhof F., Goekoop R., Stam C.J., and Scheltens P. Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study. Hum. Brain Mapp. 26 (2005) 231-239
69. Scarmeas N., Habeck C.G., Zarahn E., et al. Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance. NeuroImage 23 (2004) 35-45
70. Schmahmann J.D., Doyon J., Toga A.W., Petrides M., and Evans A.C. MRI Atlas of the Human Cerebellum (2000), Academic Press, San Diego
71. Schrag A., Jahanshahi M., and Quinn N. What contributes to quality of life in patients with Parkinson's disease?. J. Neurol., Neurosurg. Psychiatry 69 (2000) 308-312
72. Smith A. Symbol Digit Modalities Test (SDMT) Manual (revised) (1982), Western Psychological Services, Los Angeles
73. Spetsieris P., Ma Y., Dhawan V., Moeller J.R., and Eidelberg D. Highly automated computer-aided diagnosis of neurological disorders using functional brain imaging. Proc. SPIE: Med. Imaging 6144 (2006) (61445M61441-61412)
74. Trošt M., Su S., Su P.C., et al. Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. NeuroImage 31 (2006) 301-307
75. Wichmann T., and DeLong M.R. Pathophysiology of Parkinson's disease: the MPTP primate model of the human disorder. Ann. N. Y. Acad. Sci. 991 (2003) 199-213
76. Zgaljardic D.J., Borod J.C., Foldi N.S., and Mattis P.J. A review of the Cognitive and Behavioral Sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn. Behav. Neurol. 16 (2003) 193-210